Uterine contraction in vitro is widely used for evaluating drug efficacy on dysmenorrhea, and the oxytocin-induced strong and long-lasting uterine contractions are similar to the pathological state of the uterus in patients with dysmenorrhea. This evidence concerns the gene OXT and Dysmenorrhea.